The registered shares of Idorsia Ltd were listed on the SIX Swiss Exchange on June 16, 2017 (symbol: IDIA). Following the transfer of Actelion’s drug discovery and early-stage clinical pipeline business to Idorsia, registered Idorsia shares held by Actelion have been distributed to Actelion shareholders by way of a dividend in kind.
Get an overview of the key share data, maajor shareholders, and the shareholder structure.
Stock chart tool
Monitor Idorsia's performance on the SIX Swiss Exchange, compare to other indicies or download the historical share prices.
Several financial institutions are covering Idorsia.
Idorsia uses Vara Research GmbH, an independent data research company, to reach out to covering analysts and compile the consensus estimates.
How To Buy Stock
Idorsia shares are traded on the SIX Swiss Stock Exchange. Investors wishing to become a shareholder in Idorsia should contact their local bank with the following information:
Reuters / Bloomberg: IDIA.S / IDIA
Exchange: SIX, Switzerland
Swiss security number: 36 346 343
Bank staff will then be able to use this information to execute the transaction.
How To Register Shares
As part of our continued efforts towards good corporate governance we encourage shareholders to exercise their voting rights at the Annual General Meeting (AGM) of Idorsia Ltd.
The registration of shares is not mandatory under Swiss law. Therefore, registered shares are not automatically registered in our Share Register.
Idorsia has mandated areg.ch to administer its Share Register. Investors wishing to register their shares are kindly asked to contact their prime custodian (e.g. your banker or broker) to request a share registration form. After completing the form, your custodian will send it to areg.ch who will then take care of the registration. The custodian will receive a confirmation directly from areg.ch once the registration has taken place.